Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 63 results for "glaxo"

GlaxoSmithKline adult shingles vaccine wins U.S. approval | Reuters
First Post.com

GlaxoSmithKline adult shingles vaccine wins U.S. approval

(Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the ... Reuters, 21 hours ago
[x]  

12 images for glaxo

DNA, 1 week ago
First Post.com, 19 hours ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 3 months ago
Money Control, 3 months ago
Money Control, 5 months ago
Reuters, 5 months ago
Reuters, 5 months ago
Business Standard, 5 months ago
First Post.com

U.S. judge dismisses ex-sleuths' lawsuit against GlaxoSmithKline

(Reuters) - A U.S. judge has dismissed a lawsuit by two former corporate investigators who accused GlaxoSmithKline Plc (GSK) of misleading them into investigating a whistleblower in China, leading to their arrest amid a bribery scandal involving the drugmaker.
 Business Standard2 weeks ago U.S. judge dismisses ex  First Post.com2 weeks ago
Money Control

GlaxoSmithKline Pharma in focus as board OKs Thane land sale

GlaxoSmithKline Pharmaceuticals said its board approved sale of 60 acre land in Thane to Oberoi Realty for Rs 555 crore. The announcement was made after market hours on Friday, 22 September 2017.
 Business Standard3 weeks ago GlaxoSmithKline plans to close Thane land sale by December, Bengaluru property to be next  Money Control2 months ago
Rediff.com

Why GSK is changing its strategy after 93 years

Increased price control over branded generic medicines has affected its profitability GlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time since it started its operations in the country 93 years ago. The change in strategy comes at a time when the government’ increasing price control over branded generic medicines has affected its profitability.   In the last five years, the revenue of the UK-headquartered company recorded a ...
 Rediff.com1 month ago GlaxoSmithKline sets up first team for acquisitions in 93 years  Business Standard1 month ago

Investcorp adds HDFC Chairman Deepak Parekh to international advisory board

Parekh is also the non-executive chairman in India of Siemens, GlaxoSmithKline, BAE Systems India Last Updated at September 12, 2017 16:47 IST
 Business Standard1 month ago
Money Control

GlaxoSmithKline Q1 net down 63% at Rs 26 cr on GST transition

The company had posted a net profit of Rs 72.27 crore for the same period of the previous fiscal
 Business Standard2 months ago GlaxoSmithKline Q1 net profit dives 63 pc to Rs 26 cr  DNA2 months ago

GlaxoSmithKline's new boss streamlines R&D, ditches non-core drugs

LONDON (Reuters) - GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching some non-core medicines to try to improve returns in its core pharmaceuticals business.
 Business Standard2 months ago

Reuters Health News Summary

The launches include those of Mylan's generic version of GlaxoSmithKline's blockbuster Advair and Teva's multiple sclerosis drug, Copaxone.
 DNA2 months ago

GSK's new triple lung drug beats other modern inhalers in study

GlaxoSmithKline produced clinical data on Wednesday showing its newly approved three-in-one inhaler reduced life-threatening attacks in chronic obstructive pulmonary disease (COPD) patients more than other modern treatments. Britain’s biggest drugmaker ...
 Reuters1 month ago GSK's three-in-one inhaler gets positive opinion from EU agency  Reuters1 month ago

GSK bets on pioneering cancer therapy with Adaptimmune deal

GlaxoSmithKline said it has licensed the rights to Adaptimmune’s pioneering T-cell therapy program to boost its pipeline in oncology, one of four areas its has prioritized for research and development. T-cell therapy is part of a new approach to ...
 Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less